Tag: Seiji Hirasaki
Moderna to acquire Oriciro Genomics
Moderna, Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and OriCiro Genomics K.K., a pioneer in cell-free DNA synthesis and amplification technologies, recently announced they have entered into a definitive agreement through which Moderna will acquire OriCiro for $85 million.
Featured Article
Balancing profit and sustainability in supply chains
Priorities in the supply chain are expanding, moving away from cost as the main driver behind purchasing decisions. Now, sustainability and ethical sourcing are grabbing a portion of the spotlight.
